Key Takeaways
- Revenue down 8% YoY, margin hit hard: EBITDA margin fell 670 bps to 12.0% as a sharp drop in SDA raw material prices forced the sale of high-cost inventory at new, lower prices.
- Logistics chaos compounds the pain: A severe vessel shortage and container costs spiking to $5,000-$7,500 delayed ~₹11 crore of shipments and caused production stoppages on 14 reactors.
- The SDA price reset is nearly complete: Management believes raw material prices have hit a 27-year low, with only ₹4.5-5.5 crore of old, high-cost inventory left to bleed through in Q2.
- Electrolyte inflection point is finally here: A key customer’s first automated battery line starts production in October, promising a strong volume uptick from Q3 after years of slow penetration.
- What to watch next quarter: Whether the SDA inventory drag clears as promised, freight rates normalize from September, and the Q3 electrolyte ramp actually materializes.
SDA Segment: The Price Shock
- Volume up, revenue down: SDA volumes grew 12% QoQ but revenue fell 14% because key raw material prices collapsed, forcing proportional price cuts of 15%-25% on finished products.
- The margin math: High-cost inventory was sold at newly reduced prices, compressing gross margins. This dynamic consumed the quarter and will persist into Q2 with ₹4.5-5.5 crore of old inventory still to be liquidated.
- Pricing reset details: SDA pricing fell from $12 at the start of FY24 to $9, now heading to " $7 point-something," while raw material costs dropped from nearly $21 to about $9.
- The bottom is in: Management states raw material prices have hit "rock bottom," the lowest in 27 years, and sees no room for further decline. Once old inventory clears, the mismatch between input cost and selling price should end.
- Volume demand intact: Demand has improved practically on all fronts across all segments; volume demand is not a problem. Three new large SDA customers were added during Q1, with the largest already invited to discuss a two-year supply contract.
Chintan Shah: "I feel now the prices have really stabilized kind of, I would say, because I don't see there is any space to go below further. So, this is like a rock bottom prices, which we are seeing. In some of the cases, we have not seen such kind of prices in my 27 years of history."
Logistics Disruption
- Vessel shortage crippled operations: A severe shortage of vessels serving India, caused by ships diverting to China-U.S. routes ahead of expected anti-dumping duties on EVs and batteries, delayed raw material arrivals and forced production stoppages on 14 reactors.
- Shipments stuck: Approximately ₹11 crore of finished goods could not be shipped on time. Hazardous chemical shipments to the U.S. now face three-week booking gaps.
- Container costs skyrocketed: Freight rates surged to $5,000 for Europe and $6,500-$7,500 for the U.S., eating into margins. The impact began around mid-June, so Q1 bore only a partial hit.
- Normalization expected soon: Management expects freight rates to start normalizing from September, with the disruption largely over by early September.
Chintan Shah: "But there may be some increase on account of freight, but that has been compensated by other saving in other expense. Krishan ji, the freight is impacting, but the major impact has started from end of June. Nearing 15th of June when this phenomenon has started."
Electrolyte Salts: The Inflection Point
- The long wait nears its end: Electrolytes remain at just 1% of revenue, the same level as at the IPO, but management believes the technology is now at an inflection point.
- Automated line triggers Q3 ramp: A key customer has completed setup of its first automated battery production line and begins production from early October. This is expected to drive a strong volume uptick from Q3. The customer has funding for three more automated lines over the next two years, translating into exponential volume growth.
- Hybrid car batteries progressing: Qualification for hybrid car battery electrolytes is advancing well, with commercialization expected from early 2025 and a gradual pickup thereafter.
- Super capacitor timeline: Preliminary approval received for super capacitor electrolyte salts; larger-scale customer approvals targeted by November, with slow commercialization from early 2025, real scale in 2026, and peak in 2027.
- Zinc battery opportunity: Lab-scale samples for fully formulated zinc battery electrolytes were approved by one customer. Scale-up to pilot scale begins in the next couple of months, with plant-scale commercialization expected in 1-1.5 years. Volume potential is 8,000-10,000 tons per year of formulated electrolytes.
Chintan Shah: "So, this is purely going into the automotive segment. So here we are visualizing slow commercialization to begin from early 2025 and real scale of commercialization eventually in 1 to 2 years so '26 and hitting the peak at 2027. This is what we expect."
New Product Pipeline Progress
- Pharma intermediates advancing: One pharma intermediate is fully approved with gradual commercial supply started. Two others are at the penultimate stage for early 2025 commercialization. One more has been developed with lab samples sent for preliminary approval.
- Agro intermediates delayed: Two agro intermediates are nearing approval completion, but commercial supplies face delays due to subdued agrochemical sector demand. A third was delayed by the Red Sea issue but has been consumed in a plant trial. Two more are under development using continuous flow chemistry.
- Polymer segment nears commercialization: Plant trials are underway for two products after successful pilot trials. The first product dispatch for qualification is expected in Q2, the second in Q3. An electrolysis product is currently running a 1-metric-ton plant trial, with dispatch expected by end of August.
- Polymer revenue potential: Management sees polymer segment revenue crossing ₹200 crores, with ₹250 crores as a realistic number from the current facility, though reaching that volume will take 2-3 years.
- Metal extraction and continuous flow: Regular commercial supplies of metal extraction products began in Q1 with reasonable volumes. New continuous flow chemistry pilot equipment has been received and is under installation; Monoglyme pilot trials begin in August.
- Distillation plant unlocks capacity: A new distillation plant will be commercialized from end of August, freeing reactor capacity currently used for solvent recoveries and making it available for main product production.
Chintan Shah: "In terms of revenue, I would say we can cross INR200 crores. But honestly speaking, this is again a very large volume segment, very large, massive segment. But looking at our capacities in terms of electrolysis available at the plant and the number of electrolyzers which we can expand, I would say INR250 crores is a realistic number to it from this facility."
Margins: The Damage and the Recovery Path
- 670 bps EBITDA margin drop: EBITDA margin fell to 12.0% from 18.7% YoY. COGS rose 3.3%, employee expenses 1.4%, and other expenses 2% YoY. The core margin calculation method with customers has not changed; the compression is purely from the sudden raw material price drop consuming high-cost inventory.
- Q2 carries residual drag: Approximately ₹4.5-5.5 crores of old, high-cost SDA inventory remains to be sold in Q2. Once cleared, newer, lower-cost raw materials will align with the new selling prices.
- Freight adds pressure: The spike in container costs will have a larger impact in Q2 than in Q1, since the disruption began only in mid-June.
- Full-year guidance reaffirmed: Despite the Q1 miss, management reaffirmed 20%-25% EBITDA margin guidance for the full year, calling it "not a big challenge."
- Utilization to improve: Plant utilization is expected to reach 85% by Q3, up from current levels, aided by the distillation plant freeing reactor capacity.
Chintan Shah: "You can see this even in terms of our gross margins during this quarter. Possibly we still have an inventory of SDAs, which will have an impact of roughly about INR4.5 crores to INR5.5 crores in this Q2 as well. But that will end away all our old inventories and then we have newer raw materials coming in and selling at the new price."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | At least 20% growth, can go up to 30% | FY25 full year |
| EBITDA margin | 20% to 25% | FY25 full year |
| SDA inventory drag cleared | ₹4.5-5.5 crore of old inventory sold through | End of Q2 FY25 |
| Electrolyte volume uptick | Strong uptick from customer's first automated battery line | Q3 FY25 (October) |
| Hybrid car battery electrolyte commercialization | Gradual pickup | Early 2025 |
| Pharma intermediates commercialization | Two products | Early 2025 |
| Super capacitor electrolyte commercialization | Slow start, real scale in 2026, peak in 2027 | Early 2025 onward |
| Polymer product dispatch for qualification | First product in Q2, second in Q3 | Q2/Q3 FY25 |
| Distillation plant commercialized | Frees reactor capacity | End of August 2024 |
| Freight rate normalization | Disruption to ease | Beginning of September 2024 |
| Plant utilization | Reach 85% | Q3 FY25 |
| Zinc battery electrolyte plant-scale commercialization | 1 to 1.5 years from pilot scale | ~2026-2027 |
| Polymer segment revenue | Cross ₹200 crores, reach ₹250 crores | 2-3 years |
| Electrolyte customer automated lines | Three more lines over two years | Next 2 years |
Key Metrics
| Metric | Q1 FY25 |
|---|---|
| Revenue from operations | ₹105.5 cr, 8% YoY decline, 7% QoQ growth |
| EBITDA | ₹12.6 cr, 41% YoY decrease, 19% QoQ decrease |
| EBITDA margin | 12.0%, decreased 670 bps YoY; COGS up 3.3%, employee expenses up 1.4%, other expenses up 2% YoY |
| PBT | ₹6.8 cr, vs ₹13.4 cr in Q1FY24 |
| PAT | ₹5.2 cr, vs ₹9.5 cr in Q1FY24; PAT margin 4.9% vs 8.3% YoY |
| Other income | ₹1.2 cr, vs ₹1 cr in Q1FY24; includes FOREX gain of ₹0.56 cr |
| Exports | ₹65.7 cr, 62% of revenue; major countries include USA, UK, China, Germany, Japan, South Africa |
| PTC segment revenue | ₹29.7 cr, 9% QoQ growth, 6% YoY decline |
| Electrolyte Salts segment revenue | ₹1.3 cr, 3% QoQ decrease, 2% YoY growth |
| Pharma and Agro Intermediates and Specialty Chemicals revenue | ₹38.9 cr, 39% QoQ increase, 25% YoY growth |
| SDA segment revenue | ₹35 cr, 14% QoQ decline, 29% YoY decrease; volumes up 12% QoQ but sales realization dropped nearly 23% |
| SDA price reduction | 15% to 25% across various SDAs, driven by key raw material price decline |
| Full-year EBITDA margin guidance | 20% to 25%, reaffirmed despite Q1 performance |
| Reactor occupancy | ~77%, up from ~67% in previous quarter; expected to reach 85% by Q3 after distillation plant comes online |
| Ongoing capex | ₹35 cr to ₹40 cr, for distillation facility, bromine recovery plant, and storage; additional ₹50 cr to ₹70 cr planned subject to soil testing |
| Logistics cost impact | Europe ~$5,000 per container, USA ~$6,500 to $7,500 per container; freight eating away $0.25 to $0.30 per kg |
| Delayed shipments | ~₹11 cr of material delayed, to be shipped through July and mid-August due to vessel unavailability |
| Old SDA inventory impact expected in Q2 | ₹4.5 cr to ₹5.5 cr of margin pressure from consumption of high-cost SDA inventory |